Clinical Trials Directory

Trials / Completed

CompletedNCT04969419

Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo

Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo: A Case-control Study in the United Kingdom, 2009-2020

Status
Completed
Phase
Study type
Observational
Enrollment
75,771 (actual)
Sponsor
Momentum Data · Industry
Sex
All
Age
18 Years
Healthy volunteers

Summary

This study examines melanoma and nonmelanoma skin cancer in people diagnosed with vitiligo compared to matched controls.

Detailed description

For the primary analysis, this study examines the risk of melanoma and nonmelanoma skin cancers: squamous cell carcinoma and basal cell carcinoma in people diagnosed with vitiligo. It also examines actinic keratoses. In secondary analysis, this study examines the prevalence of skin cancer in people diagnosed with vitiligo compared to matched controls. This study also examines whether the susceptibility to melanoma and nonmelanoma skin cancer may vary between different patient subgroups, e.g. ethnicity, those who undergo phototherapy or treatment with the new targeted biologic immunosuppressive therapies.

Conditions

Interventions

TypeNameDescription
OTHERExposure of skin cancer of interestMelanoma and nonmelanoma skin cancers: squamous cell carcinoma, basal cell carcinoma and actinic keratoses.

Timeline

Start date
2021-06-18
Primary completion
2022-03-31
Completion
2023-04-04
First posted
2021-07-20
Last updated
2025-01-14
Results posted
2025-01-14

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04969419. Inclusion in this directory is not an endorsement.